KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Colgate Palmolive (CL) over the last 17 years, with Q3 2025 value amounting to $420.0 million.

  • Colgate Palmolive's Dividends Paid - Common rose 294.12% to $420.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 185.29%. This contributed to the annual value of $1.8 billion for FY2024, which is 228.7% up from last year.
  • Latest data reveals that Colgate Palmolive reported Dividends Paid - Common of $420.0 million as of Q3 2025, which was up 294.12% from $474.0 million recorded in Q2 2025.
  • Colgate Palmolive's Dividends Paid - Common's 5-year high stood at $514.0 million during Q4 2024, with a 5-year trough of $376.0 million in Q1 2021.
  • For the 5-year period, Colgate Palmolive's Dividends Paid - Common averaged around $432.0 million, with its median value being $420.0 million (2021).
  • In the last 5 years, Colgate Palmolive's Dividends Paid - Common plummeted by 221.77% in 2022 and then soared by 481.65% in 2023.
  • Colgate Palmolive's Dividends Paid - Common (Quarter) stood at $496.0 million in 2021, then decreased by 2.22% to $485.0 million in 2022, then rose by 4.33% to $506.0 million in 2023, then increased by 1.58% to $514.0 million in 2024, then fell by 18.29% to $420.0 million in 2025.
  • Its Dividends Paid - Common was $420.0 million in Q3 2025, compared to $474.0 million in Q2 2025 and $406.0 million in Q1 2025.